Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan in progressive pulmonary sarcoidosis
NCT00926627Phase 2Terminated
- Start
- Apr 2009
- Primary completion
- Mar 2010
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bosentan in pulmonary sarcoidosis. Started Apr 2009; status: terminated.
02
Drugs
bosentan
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on NCT00926627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00926627.